Skip to main content
SpringerLink
Log in

An Evidence-based Perspective of Coriolus Versicolor (Multicolored Polypore Mushroom) for Cancer Patients

  • Chapter
  • First Online:
Evidence-based Anticancer Materia Medica

Abstract

In the era of molecularly targeted, rationally designed cancer therapeutics, natural products, especially medicinal mushrooms, continue to provide a rich source of anticancer agents. One potent medicinal mushroom extensively used in both traditional medicine and modern clinical practice is Coriolus versicolor (alternative names Trametes versicolor, Polyporus versicolor, Polystictus versicolor, multicolored polypore mushroom). In spite of their paucity, available data about the physical, chemical and pharmacodynamic properties of its active compounds and respectable scientific arguments support the possibility of developing at least some of the constituent molecules and metabolites into evidence-based immunotherapeutic remedies for cancer patients as part of comprehensive cancer treatment and secondary prevention strategy. In this chapter we present current knowledge about the immunological and antitumor properties of multicolored polypore mushroom constituents, and its possible applications for supportive cancer care and therapy. Modulation of innate and adaptive immunity, hematopoietic activity, and direct cytotoxic effects are reviewed with detailed analysis of molecular targets and signaling pathways affected by mushroom components and/or secondary metabolites. Data received from complementary in vivo, ex vivo and in vitro approaches are discussed. We also present some novel findings, which point to the highly different biological potency of multicolored polypore mushroom extracts and/or products from different sources and manufacturing procedures. The findings obtained from fundamental research are supplemented with information acquired from traditional usage and controlled clinical trials. Finally, we attempt to highlight the need for further evidence-based research with particular focus on potential drug interaction, contraindications and adverse effects, which should enable technological improvement of drug production.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham, W. R. (2001). Bioactive sesquiterpenes produced by fungi: Are they useful for humans as well? Current Medicinal Chemistry, 8, 583–606.

    Article  PubMed  CAS  Google Scholar 

  • Akagi, J., & Baba, H. (2010). PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients. International Journal of Clinical Oncology/Japan Society of Clinical Oncology, 15, 145–152.

    Article  CAS  Google Scholar 

  • Algarra, I., Collado, A., Garcia Lora, A., et al. (1999). Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. Journal of Experimental & Clinical Cancer Research: CR, 18, 39–46.

    CAS  Google Scholar 

  • Bohm, J. A., & BeMillar, J. N. (1995). (1-3)-βD-glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydrate Polymers, 28, 3–14.

    Article  Google Scholar 

  • Breene, W. (1990). Nutritional and medicinal value of speciality mushrooms. Journal of Food Production, 53, 883–894.

    CAS  Google Scholar 

  • Chan, S. L., & Yeung, J. H. (2006a). Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells. Food and Chemical Toxicology, 44, 689–694.

    Article  CAS  Google Scholar 

  • Chan, S. L., & Yeung, J. H. (2006b). Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse. Life Sciences, 78, 2463–2470.

    Article  CAS  Google Scholar 

  • Chan, G. C., Chan, W. K., & Sze, D. M. (2009). The effects of beta-glucan on human immune and cancer cells. Journal of Hematology Oncology, 2, 25.

    Article  PubMed  CAS  Google Scholar 

  • Chen, J., & Seviour, R. (2007). Medicinal importance of fungal beta-(1→3), (1→6)-glucans. Mycological Research, 111, 635–652.

    Article  PubMed  CAS  Google Scholar 

  • Cheng, K. F., & Leung, P. C. (2008). General review of polysaccharopeptides (PSP) from C. versicolor: Pharmacological and clinical studies. Cancer Therapy, 6, 117–130.

    CAS  Google Scholar 

  • Cheung, N. K., Modak, S., Vickers, A., et al. (2002). Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunology Immunotherapy, 51, 557–564.

    CAS  Google Scholar 

  • Chu, K. K., Ho, S. S., & Chow, A. H. (2002). Coriolus versicolor: A medicinal mushroom with promising immunotherapeutic values. Journal of Clinical pharmacology, 42, 976–984.

    PubMed  Google Scholar 

  • Cobb, B. A., Wang, Q., Tzianabos, A. O., et al. (2004). Polysaccharide processing and presentation by the MHCII pathway. Cell, 117, 677–687.

    Article  PubMed  CAS  Google Scholar 

  • Coles, M., & Toth, B. (2005). Lack of prevention of large intestinal cancer by VPS, an extract of Coriolus versicolor mushroom. In Vivo, 19, 867–871.

    PubMed  Google Scholar 

  • Collins, R. A., & Ng, T. B. (1997). Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sciences, 60, 383–387.

    Article  Google Scholar 

  • Cui, J., & Chisti, Y. (2003). Polysaccharopeptides of Coriolus versicolor: Physiological activity, uses, and production. Biotechnology Advances, 21, 109–122.

    Article  PubMed  CAS  Google Scholar 

  • Dong, Y., Kwan, C. Y., Chen, Z. N., et al. (1996). Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: In vitro and in vivo studies. Research Communications in Molecular Pathology and Pharmacology, 92, 140–148.

    PubMed  CAS  Google Scholar 

  • Ebina, T., & Kohya, H. (1988). Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation. Japanese Journal of Cancer Research: Gann, 79, 957–964.

    Article  PubMed  Google Scholar 

  • Ghoneum, M., Wimbley, M., Salem, F., et al. (1995). Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). International Journal of Immunotherapy, 11, 23–28.

    Google Scholar 

  • Gong, S., Zhang, H. Q., Yin, W. P., et al. (1998). Involvement of interleukin-2 in analgesia produced by Coriolus versicolor polysaccharide peptides. Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica, 19, 67–70.

    PubMed  CAS  Google Scholar 

  • Habelhah, H., Okada, F., Nakai, K., et al. (1998). Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: Possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K. Cancer Immunology, Immunotherapy: CII, 46, 338–344.

    Article  PubMed  CAS  Google Scholar 

  • Harhaji, L. J., Mijatovic, S., Maksimovic-Ivanic, D., et al. (2008). Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: In vitro and in vivo study. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 46, 1825–1833.

    Article  CAS  Google Scholar 

  • Hayakawa, K., Mitsuhashi, N., Saito, Y., et al. (1993). Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. Anticancer Research, 13, 1815–1820.

    PubMed  CAS  Google Scholar 

  • Ho, C. Y., Lau, C. B., Kim, C. F., et al. (2004). Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. International Immunopharmacology, 4, 1549–1557.

    Article  PubMed  CAS  Google Scholar 

  • Ho, C. Y., Kim, C. F., Leung, K. N., et al. (2005). Differential anti-tumor activity of coriolus versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells. Cancer Biology & Therapy, 4, 638–644.

    Article  Google Scholar 

  • Hobbs, C. (1995). Medicinal mushrooms. An exploration of tradition, healing and culture. Santa Cruz: Botanica Press.

    Google Scholar 

  • Hong, F., Yan, J., Baran, J. T., et al. (2004). Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Journal of Immunology (Baltimore, Md.: 1950), 173, 797–806.

    CAS  Google Scholar 

  • Hsieh, T. C., & Wu, J. M. (2001). Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells. International Journal of Oncology, 18, 81–88.

    PubMed  CAS  Google Scholar 

  • Hsieh, T. C., Kunicki, J., Darzynkiewicz, Z., et al. (2002). Effects of extracts of Coriolus versicolor (I’m-Yunity) on cell-cycle progression and expression of interleukins-1 beta,-6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. Journal of Alternative and Complementary Medicine (New York), 8, 591–602.

    Article  Google Scholar 

  • Hsieh, T. C., Wu, P., Park, S., et al. (2006). Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I’m-Yunity (PSP). BMC Complementary and Alternative Medicine, 6, 30.

    Article  PubMed  Google Scholar 

  • Iino, Y., Takai, Y., Sugamata, N., et al. (1992). PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas. Anticancer Research, 12, 2101–2103.

    PubMed  CAS  Google Scholar 

  • Iino, Y., Yokoe, T., Maemura, M., et al. (1995). Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Research, 15, 2907–2911.

    PubMed  CAS  Google Scholar 

  • Ikuzawa, M., Matsunaga, K., & Nishiyama, S. (1988). Fate and distribution of an antitumor protein-bound polysaccharide Krestin (PSK)™. International Journal of Immunopharmacology, 10, 415–23.

    Article  PubMed  CAS  Google Scholar 

  • Ito, K., Nakazato, H., Koike, A., et al. (2004). Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. International Journal of Colorectal Disease, 19, 157–164.

    Article  PubMed  Google Scholar 

  • Jiménez, E., Garcia-Lora, A., Martinez, M., et al. (2005). Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells. Cancer Immunology Immunotherapy, 54, 395–399.

    Article  CAS  Google Scholar 

  • Jiménez-Medina, E., Berruguilla, E., Romero, I., et al. (2008). The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer, 8, 78.

    Article  PubMed  CAS  Google Scholar 

  • Jong, S. C., Birmingham, J. M., & Pai, S. H. (1991). Immunomodulatory substances of fungal origin. Journal of Immunology Immunopharmacology, 3, 115–122.

    Google Scholar 

  • Kanazawa, M., Mori, Y., Yoshihara, K., et al. (2004). Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunology Letters, 91, 229–238.

    Article  PubMed  CAS  Google Scholar 

  • Kanoh, T., Matsunaga, K., Saito, K., et al. (1994). Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK. In Vivo, 8, 247–250.

    PubMed  CAS  Google Scholar 

  • Katano, M., Yamamoto, Y., & Torisu, M. (1987). A suppressive effect of PSK, protein-bound polysaccharide preparation, on tumor growth: A new effect of PSK on cell motility. Japanese Journal of Cancer & Chemotherapy, 14, 2321–2326.

    CAS  Google Scholar 

  • Katoh, R., & Ooshiro, M. (2007). Enhancement of antitumor effect of tegafur/uracil (UFT) plus leucovorin by combined treatment with protein-bound polysaccharide, PSK, in mouse models. Cellular & Molecular Immunology, 4, 295–299.

    CAS  Google Scholar 

  • Katoh, R., Takenoshita, S., Shimizu, Y., et al. (1997). Changes in serum soluble IL-2 receptors (sIL-2R) and immunosuppressive acidic protein (IAP) associated with chemotherapy for lung cancer. Anticancer Research, 17, 3787–3792.

    PubMed  CAS  Google Scholar 

  • Kawa, K., Konishi, S., Tsujiino, G., et al. (1991). Effects of biological response modifiers on childhood ALL being in remission after chemotherapy. Biomedecine & Pharmacotherapy, 45, 113–116.

    Article  CAS  Google Scholar 

  • Kidd, P. M. (2000). The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review: A Journal of Clinical Therapeutic, 5, 4–27.

    CAS  Google Scholar 

  • Kim, F., Sakagami, H., Tanuma, S., et al. (1990). Stimulation of interferon-gamma-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction. Anticancer Research, 10, 55–58.

    PubMed  CAS  Google Scholar 

  • Kim, M. Y., Seguin, P., Ahn, J. K., et al. (2008). Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. Journal of Agricultural and Food Chemistry, 56, 7265–7270.

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi, H., Matsunaga, K., & Fujii, M. (1993). PSK as a chemopreventive agent. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2, 271–276.

    CAS  Google Scholar 

  • Kobayashi, Y., Kariya, K., Saigenji, K., et al. (1994). Enhancement of anti-cancer activity of cis-diaminedichloroplatinum by the protein-bound polysaccharide of Coriolus versicolor QUEL (PS-K) in vitro. Cancer Biother, 9, 351–358.

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi, H., Matsunaga, K., & Oguchi, Y. (1995). Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: An overview. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 4, 275–281.

    CAS  Google Scholar 

  • Koda, K., Miyazaki, M., Sarashina, H., et al. (2003). A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. International Journal of Oncology, 23, 165–172.

    PubMed  CAS  Google Scholar 

  • Kohgo, Y., Hirayama, Y., Sakamaki, S., et al. (1994). Improved recovery of myelosuppression following chemotherapy in mice by combined administration of PSK and various cytokines. Acta Haematologica, 92, 130–135.

    Article  PubMed  CAS  Google Scholar 

  • Kondo, M., & Torisu, M. (1985). Evaluation of an anticancer activity of a protein-bound polysaccharide PS-K (Krestin). In M. Torisu & T. Yoshida (Eds.), Basic mechanisms and clinical treatment of tumor metastasis (p. 623). New York: Academic Press.

    Google Scholar 

  • Kudo, S., Tanaka, J., Kashida, H., et al. (2002). Effectiveness of immunochemotherapy with PSK, a protein bound polysaccharide, in colorectal cancer and changes of tumor marker. Oncology Reports, 9, 635–638.

    PubMed  CAS  Google Scholar 

  • Li, W., Liu, M., Lai, S., et al. (2010). Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways. Immunopharmacology and Immunotoxicology, 32, 576–584.

    Article  PubMed  CAS  Google Scholar 

  • Liu, J. X., & Zhou, J. Y. (1993). Phase II clinical trial for PSP capsules. In Q. Y. Yang & C. Y. Kwok (Eds.), Proceedings of PSP International Symposium (pp. 183–208). Shanghai: Fudan University Press.

    Google Scholar 

  • Liu, F., Fung, M. C., Ooi, V. E. C., et al. (1996). Induction in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. Life Sciences, 58, 1795–1803.

    Article  PubMed  CAS  Google Scholar 

  • Liu, F., Ooi, V. E., & Chang, S. T. (1997). Free radical scavenging activities of mushroom polysaccharide extracts. Life Sciences, 60, 763–771.

    Article  PubMed  CAS  Google Scholar 

  • Liu, J., Zhou, J., & Liu, T. (1999). Phase III clinical trial for Yun Zhi polysaccharopeptide (PSP) capsules. In Q. Yang (Ed.), Advanced research in PSP (pp. 295–303). Hong Kong: Hong Kong Association for Health Care Ltd.

    Google Scholar 

  • M. D. Anderson Cancer Center. (2010). http://www.coriolusversicolor.us/2010/07/25/md-anderson-cancer-center-coriolus-versicolor/. Accessed 31 July 2010.

  • Mao, X. W., Archambeau, J. O., & Gridley, D. S. (1996). Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. Cancer Biotherapy & Radiopharmaceuticals, 11, 393–403.

    Article  CAS  Google Scholar 

  • Matsunaga, K., Iijima, H., Aota, M., et al. (1992). Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK. Journal of Clinical & Laboratory Immunology, 37, 21–37.

    CAS  Google Scholar 

  • Matsunaga, K., Iijima, H., & Kobayashi, H. (2000). Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 9, 1313–1322.

    CAS  Google Scholar 

  • Mattila, P., Könkö, K., Eurola, M., et al. (2001). Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. Journal of Agricultural and Food Chemistry, 49, 2343–2348.

    Article  PubMed  CAS  Google Scholar 

  • Mau, J. L., Lin, H. C., & Chen, C. C. (2001). Non-volatile components of several medicinal mushrooms. Food Research International, 34, 521–526.

    Article  CAS  Google Scholar 

  • Mau, J. L., Lin, H. C., & Chen, C. C. (2002). Antioxidant properties of several medicinal mushrooms. Journal of Agricultural and Food Chemistry, 50, 6072–6077.

    Article  PubMed  CAS  Google Scholar 

  • Mayer, P., & Drews, J. (1980). The effect of a protein-bound polysaccharide from Coriolus versicolor on immunological parameters and experimental infections in mice. Infection, 8, 13–21.

    Article  PubMed  CAS  Google Scholar 

  • Mickey, D. D. (1985). Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma. Cancer Chemotherapy and Pharmacology, 15, 54–58.

    Article  PubMed  CAS  Google Scholar 

  • Mitomi, T., Tsuchiya, S., Iijima, N., et al. (1992). Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Diseases of the Colon and Rectum, 35, 123–130.

    Article  PubMed  CAS  Google Scholar 

  • Mizuno, T. (1999). The extraction and development of antitumour-active polysaccharides from medicinal mushrooms in Japan. International Journal of Medicinal Mushrooms, 1, 9–29.

    Article  CAS  Google Scholar 

  • Mizuno, T., Saito, H., Nishitoba, T., et al. (1995). Antitumor active substances from mushrooms. Food Reviews International, 11, 23–61.

    Article  CAS  Google Scholar 

  • Modak, S., Koehne, G., Vickers, A., et al. (2005). Rituximab therapy of lymphoma is enhanced by orally administered (1−>3),(1−>4)-D-beta-glucan. Leukocyte Research, 29, 679–683.

    Article  CAS  Google Scholar 

  • Monro, J. A. (2003). Treatment of cancer with mushroom products. Archives of Environmental Health, 58, 533–537.

    Article  PubMed  Google Scholar 

  • Moradali, M. F., Mostafavi, H., Ghods, S., et al. (2007). Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology, 7, 701–724.

    Article  PubMed  CAS  Google Scholar 

  • Morimoto, T., Ogawa, M., Orita, K., et al. (1996). Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan. European Journal of Cancer, 32, 235–242.

    Article  Google Scholar 

  • Nagao, T., Komatsuda, M., Yamauchi, K., et al. (1981). Chemoimmunotherapy with Krestin in acute leukemia. The Tokai Journal of Experimental and Clinical Medicine, 6, 141–146.

    PubMed  CAS  Google Scholar 

  • Nakajima, T., Ichikawa, S., Uchida, S., et al. (1990). Effects of a protein-bound polysaccharide from a basidiomycetes against hepatocarcinogenesis induced by 3’-methyl-4-dimethylaminobenzene in rats. Clinical Therapeutics, 12, 385–392.

    PubMed  CAS  Google Scholar 

  • Nakazato, H., Koike, A., Saji, S., et al. (1994). Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet, 343, 1122–1126.

    Article  PubMed  CAS  Google Scholar 

  • Nathan, C. F., & Hibbs, J. B. (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Current Opinion in Immunology, 3, 65–70.

    Article  PubMed  CAS  Google Scholar 

  • Ng, T. B. (1998). A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). General Pharmacology, 30, 1–4.

    Article  PubMed  CAS  Google Scholar 

  • Ng, T. B., & Chan, W. Y. (1997). Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice. General Pharmacology, 29, 269–273.

    Article  PubMed  CAS  Google Scholar 

  • Ng, T. B., Wang, H. X., Liu, F., et al. (1999). Polysaccharopeptide (PSP) from mycelia of the mushroom Coriolus versicolor: an updated review. In Q. Y. Yang (Ed.), Advanced Research in PSP (pp. 80–87). Hong Kong: Hong Kong Association for Health Care.

    Google Scholar 

  • Niimoto, M., Hattori, T., Tamada, R., et al. (1988). Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. The Japanese Journal Surgery, 18, 681–686.

    Article  CAS  Google Scholar 

  • Nio, Y., Tsubono, M., Tseng, C. C., et al. (1992). Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Biotherapy, 4, 117–128.

    Article  PubMed  CAS  Google Scholar 

  • Nishiwaki, Y., Furuse, K., Fukuoka, M., et al. (1990). A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The advanced lung cancer immuno-chemotherapy study group. Gan to kagaku ryoho. Cancer & Chemotherapy, 17, 131–136.

    CAS  Google Scholar 

  • Oba, K., Teramukai, S., Kobayashi, M., et al. (2007). Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunology, Immunotherapy: CII, 56, 905–911.

    Article  PubMed  CAS  Google Scholar 

  • Ogoshi, K., Satou, H., Isono, K., et al. (1995a). Immunotherapy for esophageal cancer: A randomized trial in combination with radiotherapy and radiochemotherapy. American Journal of Clinical Oncology, 18, 216–222.

    Article  CAS  Google Scholar 

  • Ogoshi, K., Satou, H., Isono, K., et al. (1995b). Possible predictive markers of immunotherapy in esophageal cancer: Retrospective analysis of a randomized study. Cancer Investigation, 13, 363–369.

    Article  CAS  Google Scholar 

  • Ogoshi, K., Tajima, T., Mitomi, T., et al. (1997). HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer. Cancer Immunology, Immunotherapy: CII, 45, 53–59.

    Article  PubMed  CAS  Google Scholar 

  • Ogoshi, K., Miyaji, M., Nakamura, K., et al. (1998). Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants. Cancer Immunology, Immunotherapy: CII, 46, 14–20.

    Article  PubMed  CAS  Google Scholar 

  • Oguchi, Y., Ando, T., Matsunaga, K., et al. (1987). Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice. Anticancer Research, 7, 681–684.

    PubMed  CAS  Google Scholar 

  • Ohno, R., Yamada, K., Masaoka, T., et al. (1984). A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunology, Immunotherapy: CII, 18, 149–154.

    Article  PubMed  CAS  Google Scholar 

  • Ohwada, S., Ikeya, T., Yokomori, T., et al. (2004). Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: A randomised controlled study. British Journal of Cancer, 90, 1003–1010.

    Article  PubMed  CAS  Google Scholar 

  • Ohwada, S., Ogawa, T., Makita, F., et al. (2006). Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: Analysis of immunological parameters. Oncology Reports, 15, 861–868.

    PubMed  CAS  Google Scholar 

  • Park, S., Jang, S. A., Lim, J. D., et al. (2009). Phagocytic effects of β-glucan from Coriolus versicoloar are related with Dectin-1 signaling and NOS and Ikaros regulation in macrophages. Meeting Abstract The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 23, 1003–1009.

    Google Scholar 

  • Poyrazoglu Çoban, E., Isman, B., & Biyik, H. H. (2008). Effects of protein-bound polysaccharide against some microorganisms. Türk Mikrobiyoloji Cemiyeti/Turkish Microbiological Society, 38, 150–155.

    Google Scholar 

  • Price, L. A., Wenner, C. A., Sloper, D. T., et al. (2010). Role for toll-like receptor 4 in TNF-alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract. Fitoterapia, 81, 914–919.

    Article  PubMed  CAS  Google Scholar 

  • Quian, Z. M., Xu, M. F., & Tang, P. L. (1997). Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. The American Journal of Chinese Medicine, 25, 27–35.

    Article  Google Scholar 

  • Ragupathi, G., Yeung, K. S., Leung, P. C., et al. (2008). Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine, 26, 4860–4865.

    Article  PubMed  Google Scholar 

  • Rau, U., Kuenz, A., Wray, V., et al. (2009). Production and structural analysis of the polysaccharide secreted by Trametes (Coriolus) versicolor ATCC 200801. Applied Microbiology and Biotechnology, 81, 827–837.

    Article  PubMed  CAS  Google Scholar 

  • Roeder, A., Kirschning, C. J., Rupec, R. A., et al. (2004). Toll-like receptors as key mediators in innate antifungal immunity. Medical Mycology: Official Publication of the International Society for Human and Animal Mycology, 42, 485–498.

    Article  CAS  Google Scholar 

  • Sadahiro, S., Suzuki, T., Maeda, Y., et al. (2010). Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. Anticancer Research, 30, 993–999.

    PubMed  CAS  Google Scholar 

  • Saji, S., Sakamoto, J., Teramukai, S., et al. (1999). Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: Covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Surgery Today, 29, 504–510.

    Article  PubMed  CAS  Google Scholar 

  • Sakagami, H., & Aoki, T. (1991). Induction of immunopotentiation activity by a protein-bound polysaccharide. PSK (review). Anticancer Research, 11, 993–1000.

    PubMed  CAS  Google Scholar 

  • Sakamoto, J., Morita, S., Oba, K., et al. (2006). Meta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials. Cancer Immunology, Immunotherapy: CII, 55, 404–411.

    Article  PubMed  CAS  Google Scholar 

  • Sakita, M., Imai, H., Yamane, T., et al. (1982). Effect of PSK on dimethyl hydnazine (DMH) induction of intestinal tumors in rats. Japanese Journal of Cancer Chemotherapy, 9, 1216–1225.

    CAS  Google Scholar 

  • Schmidt, C. (2006). Immune system’s Toll-like receptors have good opportunity for cancer treatment. Journal of the National Cancer Institute, 98, 574–575.

    Article  PubMed  Google Scholar 

  • Shibata, M., Nezu, T., Kanou, H., et al. (2002). Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Investigation, 20, 166–173.

    Article  PubMed  CAS  Google Scholar 

  • Shimokawa, K., Mashima, I., Asai, A., et al. (2008). Biological activity, structural features, and synthetic studies of (-)-ternatin, a potent fat-accumulation inhibitor of 3T3-L1 adipocytes. Chemistry, an Asian Journal, 3, 438–446.

    Article  PubMed  CAS  Google Scholar 

  • Shiu, W. C. T., Leung, T. W., & Tao, M. (1993). A clinical study of PSP on peripheral blood cell counts during chemotherapy. In Q. Y. Yang & C. Y. Kwok (Eds.), Proceedings of PSP International Symposium (pp. 216–220). Shanghai: Fudan University Press.

    Google Scholar 

  • Simon, H. U., Haj-Yehia, A., & Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis, 5, 415–418.

    Article  PubMed  CAS  Google Scholar 

  • Smith, J. E., Rowan, N., & Sullivan, R. (2002). Medicinal mushrooms: Their therapeutic properties and current medicinal usage with special emphasis on cancer treatment. http://sci.cancerresearchuk.org/labs/med_mush/med_mush.html.

  • Standish, L. J., Wenner, C. A., Sweet, E. S., et al. (2008). Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society for Integrative Oncology, 6, 122–128.

    PubMed  Google Scholar 

  • Sullivan, R., Smith, J. E., & Rowan, N. J. (2006). Medicinal mushrooms and cancer therapy; translating a traditional practice into Western medicine. Perspectives in Biology and Medicine, 49, 159–170.

    Article  PubMed  CAS  Google Scholar 

  • Takeuchi, T., Iinuma, H., Iwanaga, J., et al. (1969). Coriolin, a new Basidiomycetes antibiotic. The Journal of Antibiotics, 22, 215–217.

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, K., Wakasugi, J., Seki, F., et al. (1991). Effect of PSK on cell growth, chemotaxis and platelet aggregating activity of colon 26 cell line. Proceedings of the 50th annual Japanese cancer association meeting, p. 263.

    Google Scholar 

  • Taylor, P. R., Brown, G. D., Herre, J., et al. (2004). The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macro-phages. Journal of Immunology (Baltimore, Md.: 1950), 172, 1157–1162.

    CAS  Google Scholar 

  • Toge, T., & Yamaguchi, Y. (2000). Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncology Reports, 7, 1157–1161.

    PubMed  CAS  Google Scholar 

  • Toi, M., Hattori, T., Akagi, M., et al. (1992). Randomized adjuvant trial to evaluate the addition of Tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-year results from the Nishi-Nippon group of the adjuvant chemoendocrine therapy for breast cancer organization. Cancer, 70, 2475–2483.

    Article  PubMed  CAS  Google Scholar 

  • Torisu, M., Hayashi, Y., Ishimitsu, T., et al. (1990). Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunology, Immunotherapy: CII, 31, 261–268.

    Article  PubMed  CAS  Google Scholar 

  • Tsang, K. W., Lam, C. L., Yan, C., et al. (2003). Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respiratory Medicine, 97, 618–624.

    Article  PubMed  CAS  Google Scholar 

  • Tsuji, K., Takagi, M., Kobayashi, T., et al. (1989). Effect of a protein-bound polysaccharide, PSK, on human hemopoietic progenitors. Nippon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society, 52, 594–600.

    PubMed  CAS  Google Scholar 

  • Wan, J. M., Sit, W. H., & Louie, J. C. (2008). Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. International Journal of Oncology, 32, 689–699.

    PubMed  CAS  Google Scholar 

  • WHO (2000). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines. World Health Organization, Geneva.

    Google Scholar 

  • Wong, C. K., Tse, P. S., Wong, E. L., et al. (2004). Immunomodulatory effects of yun zhi and danshen capsules in health subjects–a randomized, double-blind, placebo-controlled, crossover study. International Immunopharmacology, 4, 201–211.

    Article  PubMed  CAS  Google Scholar 

  • Wong, C. K., Bao, Y. X., Wong, E. L., et al. (2005). Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. The American Journal of Chinese Medicine, 33, 381–395.

    Article  PubMed  Google Scholar 

  • Wu, Z., Chen, C., & Chen, Y. M. (1993). Clinical observation of esophageal cancer treatment by radiotherapy together with the oral administration of PSP. In Q. Y. Yang & C. Y. Kwok (Eds.), Proceedings of PSP International Symposium (pp. 265–268). Shanghai: Fudan University Press.

    Google Scholar 

  • Xu, Q., Lu, J., Wang, R., et al. (1997). Liver injury model induced in mice by a cellular immunologic mechanism—study for use in immunopharmacological evaluations. Pharmacological Research: The Official Journal of the Italian Pharmacological Society, 35, 273–278.

    Article  CAS  Google Scholar 

  • Yamasaki, A., Shoda, M., Iijima, H., et al. (2009). A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. Anticancer Research, 29, 843–850.

    PubMed  CAS  Google Scholar 

  • Yamashita, K., Ougolkov, A. V., Nakazato, H., et al. (2007). Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic beta-catenin activation. Diseases of the Colon and Rectum, 50, 1169–1181.

    Article  PubMed  Google Scholar 

  • Yang, Q. Y. (1999). Yun Zhi polysaccharopeptide (PSP) and the general aspects of its research. In Q. U. Yang (Ed.), Advanced Research in PSP (pp. 29–38). Hong Kong: The Hong Kong Assocation for Health Care Ltd.

    Google Scholar 

  • Yang, M. M., Chen, Z., & Kwok, J. S. (1992). The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV). The American Journal of Chinese Medicine, 20, 221–232.

    Article  PubMed  CAS  Google Scholar 

  • Yang, X., Sit, W. H., Chan, D. K., et al. (2005). The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. Oncology Reports, 13, 1201–1210.

    PubMed  CAS  Google Scholar 

  • Yeung, J. H., Chiu, L. C., & Ooi, V. E. (1994). Effect of polysaccharide peptide (PSP) on glutathione and protection against paracetamol-induced hepatotoxicity in the rat. Methods and Findings in Experimental and Clinical Pharmacology, 16, 723–729.

    PubMed  CAS  Google Scholar 

  • Yokoe, Y., Kato, H., Takemura, S., et al. (1979). Effect of long-term administration of OK-432 (picibanil), PSK (Krestin) and levamisole on immune responses in aged subjects without malignancy. Japanese Journal of Clinical Oncology, 9, 209–214.

    Google Scholar 

  • Yokoe, T., Iino, Y., Takei, H., et al. (1997). HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Anticancer Research, 17, 2815–2818.

    PubMed  CAS  Google Scholar 

  • Yoshikawa, T., Furukawa, Y., Wakamatsu, Y., et al. (1982). Protection by BCG, levamisole, PS-K, OK-432, and vitamin E against carbon tetrachloride hepatotoxicity. Hepatogastroenterology, 29, 240–242.

    PubMed  CAS  Google Scholar 

  • Zeng, F., Hon, C. C., Sit, W. H., et al. (2005). Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. International Journal of Oncology, 27, 513–523.

    PubMed  CAS  Google Scholar 

  • Zhang, H., Morisaki, T., Matsunaga, H., et al. (2000). Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. Clinical & Experimental Metastasis, 18, 343–352.

    CAS  Google Scholar 

  • Zhou, J. X., Li, X. Y., & Shen, X. L. (1988). The anti-tumor and immunomodulating activity of PSP in mice. Journal of Shanghai Teachers University (Natural Sciences Education), 3, 72.

    Google Scholar 

  • Zhou, Y. L., & Yang, Q. Y. (1999). Active principles from Coriolus sp. In Q. U. Yang (Ed.), Advances research in PSP (pp. 111–124). Hong Kong: Hong Kong Association for Health Care.

    Google Scholar 

  • Zimmerman, J. W., Lindermuth, J., Fish, P. A., et al. (1998). A novel carbohydrate-glycosphingolipid interaction between a beta -(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. The Journal of Biological Chemistry, 273, 22014–22020.

    Article  PubMed  CAS  Google Scholar 

  • Zjawiony, J. (2004). Biologically active compounds from Aphyllophorales (Polypore) fungi. Journal of Natural Products, 67, 300–310.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by the Serbian Ministry of Science (Grant 173013).

Author information

Authors and Affiliations

  1. Department of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Bulevar Despota Stefana 142, 11060, Belgrade, Serbia

    Stanislava Stošić-Grujičić

  2. Department of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Belgrade, Serbia

    Sanja Mijatović & Danijela Maksimović-Ivanić

Authors
  1. Stanislava Stošić-Grujičić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanja Mijatović
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danijela Maksimović-Ivanić
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stanislava Stošić-Grujičić .

Editor information

Editors and Affiliations

  1. Dept. Clinical Oncology, Queen Elizabeth Hospital, Gascoigne Road 30, Kowloon, Hong Kong/PR China

    William C.S. Cho

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Stošić-Grujičić, S., Mijatović, S., Maksimović-Ivanić, D. (2011). An Evidence-based Perspective of Coriolus Versicolor (Multicolored Polypore Mushroom) for Cancer Patients. In: Cho, W. (eds) Evidence-based Anticancer Materia Medica. Evidence-based Anticancer Complementary and Alternative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0526-5_13

Download citation

Publish with us

Policies and ethics

Search

Navigation